Special report on a clinical trial looking to end breast cancer disparities; FDA advises vaccine makers to update Covid shots

A researcher wanted to make mammogram guidelines smarter for all. But first she had to learn how to get the trust of women who weren't white. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women By Angus Chen Constanza Hevia for STAT A researcher wanted to make mammogram guidelines smarter for all. But first she had to learn how to get the trust of women who weren't white. Read More FDA recommends vaccine makers update Covid-19 shots to target Omicron By Andrew Joseph Ted Jackson/AP The move comes days after an outside panel of experts called for updated vaccines in the face of new variants. Read More STAT+: A rich Republican businessman is an unlikely champion for lower hospital prices — but he's winning the fight By Rachel Cohrs Lee Klafczynski for STAT Al Hubbard is also an unlikely — and shockingly successful —advocate for lowering hospital prices in Indiana. Read More Sponsor content by American Heart Association Lawmakers: Protect patients and keep the No Surprises Act strong The No Surprises Act must remain strong to prevent patients from receiving excessive medical bills they did not expect – and often cannot afford. Lawmakers in Washington must resist attempts to weaken the law – they cannot backtrack on protecting patients from surprise medical bills. Congress and the White House need to keep the No Surprises Act strong. Learn more. Supreme Court's decision on abortion sparks health tech's Cambridge Analytica moment By Mario Aguilar Drew Angerer/Getty Images Today, in the wake of a Supreme Court decision overturning Roe v. Wade, health data privacy is getting its own Cambridge Analytica moment. Read More STAT+: New analysis of Amarin's Vascepa resurrects big questions about effectiveness By Matthew Herper Adobe Some experts say the questions require a new clinical trial to be run, and some even say the FDA should reconsider the product’s approval. Read More STAT+: Hospitals have to post their prices. Now, health insurers and employers have to publish what they pay By Bob Herman Adobe Health insurers and employers that directly pay for their workers’ medical care will have to start posting data on what they pay hospitals. Read More How dengue and Zika infections could make people more attractive to mosquitoes By Theresa Gaffney PHILIPPE HUGUEN/AFP/Getty Images New research finds that people infected with dengue virus emit higher levels of a scent that attracts even more mosquitoes. Read More Opinion: How the Dobbs decision changed my research on reproductive health technology By Catherine M. Klapperich Adobe How researchers design technologies related to reproductive health underwent a cataclysmic shift with the Supreme Court's Dobbs decision. Read More Listen: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines By Damian Garde and Meg Tirrell and Adam Feuerstein This week, our colleague Eric Boodman joins us to discuss whether HIPAA can shield reproductive health data from state law enforcement. Read More Opinion: Mainstream medicine must embrace palliative care services By John Mulder FRED DUFOUR/AFP/Getty Images Clinicians should embrace the benefits of palliative care for patients with serious illnesses instead of seeing this care as an afterthought. Read More Thursday, June 30, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser